This week a mass of newspapers touted the benefits of ibuprofen on combating Alzheimer’s disease, claiming that taking this drug daily could prevent the onset of the disease. However, these newspaper titles and claims are unwarranted, misleading, and potentially dangerous. Ibuprofen is in a class of drugs called NSAIDs, non-steroidal anti-inflammatory drugs, which taken too frequently can cause gastrointestinal bleeding. The basis of these claims comes from a preliminary research study on a saliva test that has potential to identify if someone is at risk of developing Alzheimer’s disease before the onset of symptoms. The researchers collected data from a very small sample, only 23 people who had Alzheimer’s disease and 31 without; this sample is too small to draw conclusions.
Source: NHS, March 28, 2018 https://www.nhs.uk/news/neurology/claims-ibuprofen-will-wipe-out-alzheimers-are-misleading/
Date Retrieved: March 29, 2018